XML 25 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating activities:    
Net (loss) $ (1,179,000) $ (853,000)
Adjustments to reconcile net (loss) to net cash from operating activities:    
Depreciation and amortization 4,659,000 4,808,000
Loss on write down of investment in equity securities 2,114,000 0
Loss on sale of subsidiary 0 572,000
Deferred income tax 108,000 33,000
(Gain) on foreign currency transactions 0 (161,000)
Stock based compensation expense 152,000 53,000
(Gain) on sale of assets 0 (1,000)
Other non-cash items (43,000) 0
Changes in operating assets and liabilities:    
Receivables (259,000) 431,000
Prepaid expenses and other assets 113,000 141,000
Customer deposits/deferred revenue (43,000) (37,000)
Accounts payable and accrued liabilities 535,000 (573,000)
Net cash from operating activities 6,157,000 4,413,000
Investing activities:    
Payment for purchase of property and equipment (1,517,000) (338,000)
Investment in equity securities (10,000) (4,000)
Proceeds from sale of subsidiary 0 768,000
Net cash (used in) from investing activities (1,527,000) 426,000
Financing activities:    
Principal payments on long-term debt (1,417,000) (2,457,000)
Principal payments on capital leases (2,983,000) (3,240,000)
Proceeds from long-term debt financing of property and equipment 1,036,000 0
Proceeds from certificate of deposit 9,000,000 0
Advances on line of credit 0 640,000
Payments on line of credit (8,780,000) (1,200,000)
Non-controlling interest investment in subsidiaries 27,000 102,000
Cash distributions to non-controlling interests (388,000) (748,000)
Common stock repurchased 0 (2,000)
Private placement common stock 0 1,580,000
Net cash (used in) from financing activities (3,505,000) (5,325,000)
Effect of changes in foreign exchange rates on cash 0 (8,000)
Net change in cash and cash equivalents 1,125,000 (494,000)
Cash and cash equivalents at beginning of period 1,059,000 1,909,000
Cash and cash equivalents at end of period 2,184,000 1,415,000
Supplemental cash flow disclosure:    
Cash paid during the period for Interest 1,251,000 1,604,000
Cash paid during the period for Income taxes 1,000 60,000
Schedule of non-cash investing and financing activities    
Acquisition of equipment with capital lease financing 1,343,000 2,732,000
Equipment relieved in sale of subsidiary 0 (4,921,000)
Other assets relieved in sale of subsidiary 0 (826,000)
Debt relieved in sale of subsidiary 0 5,181,000
Other liabilities relieved in sale of subsidiary 0 14,000
Net equity relieved in sale of subsidiary 0 1,351,000
OCI released to net income in sale of subsidiary 0 (779,000)
Investment released to net income in sale of subsidiary $ 0 $ (1,360,000)